![Lothar Germeroth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lothar Germeroth
Vorstandsvorsitzender bei Juno Therapeutics GmbH
Aktive Positionen von Lothar Germeroth
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Juno Therapeutics GmbH
![]() Juno Therapeutics GmbH BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Juno Therapeutics GmbH is a German company that researches and develops cellular therapies. The company is based in Munich, Germany. The CEOs of the company are David Walter Pignolet, Lothar Germeroth. Juno Therapeutics was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on May 11, 2015 for $232.80 million. | Vorstandsvorsitzender | - | - |
Repairon GmbH
![]() Repairon GmbH Repairon GmbH engages in the development, manufacture, and commercialization of induced pluripotent stem cell based tissues for organ repair. It offers therapeutic products such as tissue patches and pouches for the treatment of patients with heart failure caused by ischemic and dilatative cardiomyopathies. The company was founded by Wolfram Zimmermann in 2004 and is headquartered in Goettingen, Germany. | Vorstandsvorsitzender | 15.09.2023 | - |
Vorsitzender | 01.01.2014 | - | |
Gründer | 01.01.2014 | - |
Karriereverlauf von Lothar Germeroth
Ehemalige bekannte Positionen von Lothar Germeroth
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cytos Biotechnology AG
![]() Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - | - |
IBA GmbH
![]() IBA GmbH Medical/Nursing ServicesHealth Services IBA GmbH provides product and service solutions for life science research. Its product and service portfolio includes cell selection and expansion, cloning, transfection, recombinant protein production and assays to nucleic acid custom services. The company was founded in 1999 and is headquartered in Göttingen, Germany. | Vorstandsvorsitzender | - | - |
Personalreferent | 01.04.2002 | - |
Ausbildung von Lothar Germeroth
Max-Planck-Institute for Molecular Genetics | Doctorate Degree |
Johann Wolfgang Goethe-Universität Frankfurt am Main | Undergraduate Degree |
Statistik
International
Deutschland | 6 |
Schweiz | 2 |
Operativ
Chief Executive Officer | 3 |
Human Resources Officer | 1 |
Doctorate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
IBA GmbH
![]() IBA GmbH Medical/Nursing ServicesHealth Services IBA GmbH provides product and service solutions for life science research. Its product and service portfolio includes cell selection and expansion, cloning, transfection, recombinant protein production and assays to nucleic acid custom services. The company was founded in 1999 and is headquartered in Göttingen, Germany. | Health Services |
Cytos Biotechnology AG
![]() Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Commercial Services |
Juno Therapeutics GmbH
![]() Juno Therapeutics GmbH BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Juno Therapeutics GmbH is a German company that researches and develops cellular therapies. The company is based in Munich, Germany. The CEOs of the company are David Walter Pignolet, Lothar Germeroth. Juno Therapeutics was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on May 11, 2015 for $232.80 million. | Health Technology |
Repairon GmbH
![]() Repairon GmbH Repairon GmbH engages in the development, manufacture, and commercialization of induced pluripotent stem cell based tissues for organ repair. It offers therapeutic products such as tissue patches and pouches for the treatment of patients with heart failure caused by ischemic and dilatative cardiomyopathies. The company was founded by Wolfram Zimmermann in 2004 and is headquartered in Goettingen, Germany. |
- Börse
- Insiders
- Lothar Germeroth
- Erfahrung